Leadership Overview
Veranex has 8 executives leading key functions including strategy, finance, operations, administration, and market access.
Driven by innovation, Veranex provides comprehensive, tech-enabled services for the medical technology industry, accelerating speed to market and unifying the entire development process.
Driven by innovation, Veranex provides comprehensive, tech-enabled services for the medical technology industry, accelerating speed to market and unifying the entire development process.
Leadership Roles at Veranex
Megan Osorio - Chief Executive Officer
Megan Osorio, the Chief Executive Officer at Veranex, directs the company's overarching strategy and operational execution. Osorio guides Veranex's mission to be the premier global service provider for the medical technology sector. This leadership involves ensuring the integration of engineering and design, regulatory, clinical, and market access services to deliver accelerated speed to market for clients. Osorio focuses on driving innovation and efficiency across all development stages, from concept to commercialization. The Chief Executive Officer's role is critical in assessing development risks and ensuring market viability for Veranex's partners. By unifying the development process, Osorio enables customers to realize significant cost and time efficiencies. This strategic direction ensures Veranex maintains its position as a tech-enabled leader, supporting the complex needs of the medical technology industry worldwide. Megan Osorio's leadership ensures the company's commitment to controlled development costs and accelerated market viability assessment.
.jpg)
Patrick Donnelly - Chairman & Chief Executive Officer
Patrick Donnelly, the Chairman & Chief Executive Officer at Veranex, provides executive oversight and strategic direction for the organization. Donnelly's role encompasses guiding Veranex's long-term vision as a comprehensive, tech-enabled service provider for the medical technology industry. This involves setting the strategic agenda to accelerate speed to market and manage development costs for clients. The Chairman & Chief Executive Officer ensures that Veranex's integrated approach across engineering and design, regulatory, clinical, and market access functions delivers maximum value. Donnelly's leadership focuses on mitigating development risks and enhancing market viability assessments for medical technology innovators. By championing a unified development process, Patrick Donnelly drives efficiencies in both cost and time for Veranex's global customer base. This executive leadership ensures the company's continued growth and impact within the dynamic medtech landscape.
Melissa Boyle - Interim Chief Executive Officer
Melissa Boyle, the Interim Chief Executive Officer at Veranex, assumes leadership to ensure continuity and strategic execution during a transitional period. Boyle's responsibilities include maintaining Veranex's commitment to serving the medical technology industry with comprehensive, tech-enabled services. This interim leadership ensures that the core pillars of engineering and design, regulatory, clinical, and market access continue to operate effectively, facilitating accelerated speed to market for clients. Melissa Boyle focuses on managing development costs and mitigating risks throughout the product lifecycle. The Interim Chief Executive Officer's role is vital in assessing market viability and driving efficiencies in time and cost for Veranex's partners. Boyle ensures the unified development process remains robust, supporting clients in navigating the complexities of bringing medical technologies to market. Melissa Boyle's leadership provides stability and strategic focus during this key phase for Veranex.
Lauren Bonanno - Vice President, Chief of Staff To Chief Executive Officer and Strategic Finance
Lauren Bonanno, the Vice President, Chief of Staff To Chief Executive Officer and Strategic Finance at Veranex, provides critical support to executive leadership and manages strategic financial initiatives. Bonanno's role involves aligning operational execution with the company's strategic goals, particularly in supporting the medical technology industry's development lifecycle. This includes facilitating communication and coordination across engineering and design, regulatory, clinical, and market access functions to ensure accelerated speed to market. The Vice President, Chief of Staff To Chief Executive Officer and Strategic Finance contributes to controlling development costs and assessing market viability. Lauren Bonanno's responsibilities extend to financial planning and analysis, ensuring Veranex's tech-enabled services offer optimal cost and time efficiencies. By bridging executive strategy and financial operations, Bonanno enhances the unified development process. Lauren Bonanno's dual focus ensures strategic alignment and robust financial oversight for Veranex.
Sylvain Duval - Chief Financial Officer
Sylvain Duval, the Chief Financial Officer at Veranex, manages the company's financial strategy and fiscal operations, supporting its role as a leading service provider for the medical technology industry. Duval's oversight is critical for controlling development costs and ensuring the financial viability of Veranex's comprehensive solutions. This financial leadership ensures that clients benefit from accelerated speed to market without compromising fiscal responsibility. The Chief Financial Officer plays a key part in assessing the financial risks associated with product development and market access strategies. Sylvain Duval's expertise guides Veranex in optimizing resource allocation across engineering and design, regulatory, clinical, and market access pillars. By ensuring sound financial management, Duval supports the unified development process, enabling Veranex to deliver significant cost and time efficiencies to its global partners. Sylvain Duval's financial acumen is integral to Veranex's sustained growth and market impact.
David Dockhorn - Chief Operating Officer
David Dockhorn, the Chief Operating Officer at Veranex, directs the operational execution of the company's comprehensive service offerings for the medical technology industry. Dockhorn oversees the seamless integration of engineering and design, regulatory, clinical, and market access functions, ensuring clients achieve accelerated speed to market. This operational leadership is crucial for controlling development costs and mitigating risks across the entire concept-to-commercialization spectrum. The Chief Operating Officer focuses on optimizing internal processes to enhance efficiency and reduce time-to-market for Veranex's partners. David Dockhorn's role involves ensuring that the tech-enabled solutions provided by Veranex consistently deliver value and support market viability assessments. By managing day-to-day operations, Dockhorn ensures the unified development process functions effectively, driving cost and time efficiencies for all stakeholders. David Dockhorn's operational expertise underpins Veranex's ability to support global medtech innovation.
Michel Bourdoncle - President
Michel Bourdoncle, the President at Veranex, leads key strategic initiatives and operational oversight within the organization, reinforcing its position as a premier service provider for the medical technology industry. Bourdoncle's presidency focuses on driving the company's mission to accelerate speed to market and ensure controlled development costs for clients. This leadership role involves ensuring the effective integration of Veranex's core competencies: engineering and design, regulatory, clinical, and market access. The President is instrumental in assessing development risks and enhancing market viability for new medical technologies. Michel Bourdoncle champions the unified development process, enabling Veranex to deliver significant cost and time efficiencies. By overseeing critical business functions, Bourdoncle ensures that Veranex's tech-enabled solutions consistently meet the evolving needs of the global medtech sector. Michel Bourdoncle's strategic direction supports Veranex's commitment to innovation and client success.
Douglas Dockhorn - Chief Administrative Officer (CAO)
Douglas Dockhorn, the Chief Administrative Officer (CAO) at Veranex, oversees the essential administrative functions that support the company's comprehensive service offerings for the medical technology industry. Dockhorn ensures that the operational infrastructure is optimized to facilitate accelerated speed to market and controlled development costs for clients. This role is vital in managing the internal resources that enable Veranex's integrated approach across engineering and design, regulatory, clinical, and market access. The Chief Administrative Officer (CAO) focuses on streamlining processes to mitigate development risks and enhance overall operational efficiency. Douglas Dockhorn's leadership ensures that the company's administrative framework supports the unified development process, driving cost and time efficiencies. By managing key administrative operations, Dockhorn contributes to Veranex's ability to provide reliable and effective solutions, supporting market viability assessments for medical technology innovators. Douglas Dockhorn's administrative expertise is foundational to Veranex's operational success.
Explore Leadership Teams in Business Services
Founded in 1989 and headquartered in San Francisco, California, Cornerstone Research is a financial, economic, and litigation consulting firm.
Company Leadership AS
Chemonics International is a private international development organization that partners with bilateral and multilateral donors alongside private sector entities to design and execute complex development initiatives across emerging markets. The company brings specialized expertise in project management, technical assistance, and capacity building to address critical challenges in global development. The organization operates across multiple sectors including agriculture, health, education, governance, and economic growth. Chemonics International combines field-based implementation experience with strategic advisory services, enabling clients to achieve measurable development outcomes. The company's approach integrates local knowledge with international best practices, ensuring that solutions are both contextually appropriate and scalable. This methodology has allowed the organization to build lasting partnerships with governments, civil society organizations, and community stakeholders in the regions where it operates. Chemonics International maintains a robust operational infrastructure that supports project delivery across diverse geographies and sectors. The company employs professionals with deep sectoral knowledge and regional expertise, enabling sophisticated program design and adaptive management.
Company Leadership ZK
NT
MV
GN
Founded in 1997, Info-Tech Research Group is an information technology research and advisory company whos data-driven programs enable IT leaders to objectively measure success, develop an IT strategy, and systematically improve performance year over year. Info-Tech Research Group is based in Ontario, Canada.
Company Leadership KS
KR
PB
Founded in the early 2000s and headquartered in St. Louis, Missouri, Lumeris Inc is a value-based care managed services operator for health systems and providers. Lumeris aligns providers and payers across populations with technologies, processes, behaviors, and information to achieve cost-effective care with consumers and physicians.
Company Leadership
JH
JC
Frequently Asked Questions Regarding Veranex Top Executives and Leadership Team
